Generative AI chatbot for doctors called 'Prof. Valmed' earns E.U. approval. In the U.S., FDA is yet to issue guidelines on ...

Mehmet Oz, head of the Centers for Medicare and Medicaid Services, has played a key role in convincing congressional holdouts ...

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

Good morning, it’s the third of July. This newsletter will be off tomorrow for the holiday and — surprise — all of next week.

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Woebot Health this week shut down its core product, a pioneering therapy chatbot. Its demise was hastened by the new wave of ...

Researchers in Democratic congressional districts stand to have $2.1 billion in NIH grants reinstated, compared to $62 ...

As GOP leadership pushes to pass President Trump’s tax megabill this week, one administration official has been working hard ...

Forget tariffs. Another tool of economic statecraft is far better suited to the problem of illegally manufactured fentanyl.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

Latoya Maddox, an activist, on the fight to protect the needs of disabled Americans, as time runs out to save their ...

Over 660 million pilgrims gathered at the Maha Kumbh Mela in Prayagraj, India, this past February, and I'm now seeing the ...